1. Neurological music therapy during the COVID-19 outbreak: updates and future challenges

   • Claudia Vinciguerra
   • Antonio Federico

   COVID-19 01 March 2022 Pages: 3473 - 3478

2. Comprehensive telemedicine solution for remote monitoring of Parkinson’s disease patients with orthostatic hypotension during COVID-19 pandemic

   • Paola Polverino
   • Miloš Ajčević
   • Paolo Manganotti

   COVID-19 Open access 17 March 2022 Pages: 3479 - 3487

   

3. Are COVID-19 vaccines safe for people with epilepsy? A cross-sectional study

   • Hüseyin Nezih Özdemir
   • Birgül Dere
   • Ahmet Gökçay

   COVID-19 27 February 2022 Pages: 3489 - 3496

4. Self-reported impact of the COVID-19 pandemic and lockdown on young patients with tic disorders: findings from a case–control study

   • Cristiano Termine
   • Vera Galli
   • Andrea Eugenio Cavanna

   COVID-19 Open access 11 March 2022 Pages: 3497 - 3501

   

5. Central nervous system adverse events after ChAdOx1 vaccination

   • Boby Varkey Maramattom
   • Radhika Sanjay Lotlikar
   • Sajith Sukumaran

   Brief Communication 11 March 2022 Pages: 3503 - 3507

   

6. Acute cerebellitis requiring posterior fossa decompression after COVID-19 vaccination in an ocrelizumab-treated patient with multiple sclerosis

   • Gregor Brecl Jakob
   • Lina Savšek
   • Bernard Meglič

   COVID-19 28 February 2022 Pages: 3509 - 3511

   

7. A case of anti-MOG antibody-positive ADEM following COVID-19 mRNA vaccination

   • Katsuichi Miyamoto
   • Jinsoo Koh
   • Hidefumi Ito

   COVID-19 19 March 2022 Pages: 3513 - 3514

   

8. Isolated musculocutaneous involvement in neuralgic amyotrophy associated with SARS-CoV2 vaccination

   • Carlo Civardi
   • Carmen Delconte
   • Claudio Geda

   COVID-19 15 March 2022 Pages: 3515 - 3517

   

9. COV-BT Ire study: safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with brain tumors

   • Antonio Tanzilli
   • Andrea Pace
   • Veronica Villani

   COVID-19 09 April 2022 Pages: 3519 - 3522

10. Evidences of emerging pain consciousness during prenatal development: a narrative review

    • Raffaele Falsaperla
    • Ausilia Desiree Collotta
    • Martino Ruggieri

    Review Article Open access 04 March 2022 Pages: 3523 - 3532

    

11. Update on the medial longitudinal fasciculus syndrome

    • Seung-Han Lee
    • Jae-Myung Kim
    • Ji-Soo Kim

    Review Article 08 March 2022 Pages: 3533 - 3540

    

12. Effect of GBA gene variants on clinical characteristics of dementia with Lewy bodies: a review and meta-analyses

    • Li Liu
    • Jia Li
    • Jiajun Chen

    Review Article 24 March 2022 Pages: 3541 - 3550

    

13. Efficacy and safety of endovascular treatment with or without intravenous alteplase in acute anterior circulation large vessel occlusion stroke: a meta-analysis of randomized controlled trials

    • Jun Zhang
    • Cong Yuan
    • Jin Hu

    Review Article 22 March 2022 Pages: 3551 - 3563

    

14. Sphingosine-1-phosphate receptor modulators versus interferon beta for the treatment of relapsing–remitting multiple sclerosis: findings from randomized controlled trials

    • Siyuan Yang
    • Xiang Li
    • Gang Chen

    Review Article 03 March 2022 Pages: 3565 - 3581

    

15. Paraneoplastic neurological syndrome: growing spectrum and relevance

    • Valakunja Harikrishna Ganaraja
    • Mohamed Rezk
    • Divyanshu Dubey

    Review Article 23 April 2022 Pages: 3583 - 3594

16. Relationship between self-perceived driving ability and neuropsychological performance in neurological and psychiatric patients

    • Teresa Difonzo
    • Michela Martini
    • Andrea Stracciari

    Original Article 29 January 2022 Pages: 3595 - 3601

17. Mortality of Parkinson’s disease in Italy from 1980 to 2015

    • Monica Ulivelli
    • Daiana Bezzini
    • Simone Rossi

    Original Article 30 January 2022 Pages: 3603 - 3611

    

18. The Italian version of the alternative form of Parkinson’s Disease-Cognitive Rating Scale (PD-CRS/AF): normative values from 260 Italian healthy subjects

    • Alfonsina D’Iorio
    • Gianpaolo Maggi
    • Gabriella Santangelo

    Original Article 27 January 2022 Pages: 3613 - 3620

19. Evaluation of rest tremor in different positions in Parkinson’s disease and essential tremor plus

    • Rita Nisticò
    • Andrea Quattrone
    • Aldo Quattrone

    Original Article 15 January 2022 Pages: 3621 - 3627

    

20. Comparison of the mass and amount of intramuscular non-contractile tissue of the trunk and lower extremity muscles between patients with Parkinson’s disease and community-dwelling older adults

    • Mitsuhiro Masaki
    • Maki Kasahara
    • Shunsuke Obinata

    Original Article 18 January 2022 Pages: 3629 - 3640

    

21. Do neuropsychiatric fluctuations temporally match motor fluctuations in Parkinson’s disease?

    • Eleonora Del Prete
    • Emmanuelle Schmitt
    • Elena Moro

    Original Article 19 January 2022 Pages: 3641 - 3647

    

22. Polymorphisms of the dopamine metabolic and signaling pathways are associated with susceptibility to motor levodopa-induced complications (MLIC) in Parkinson’s disease: a systematic review and meta-analysis

    • Gita Vita Soraya
    • Zulvikar Syambani Ulhaq
    • Muhammad Akbar

    Original Article 25 January 2022 Pages: 3649 - 3670

    

23. Association of HMOX-1 rs2071747 with sporadic Parkinson’s disease in southern Han Chinese

    • Ran Xiong
    • Bei Zhang

    Original Article 10 January 2022 Pages: 3671 - 3675

24. Uncovering clinical and radiological asymmetry in progressive supranuclear palsy—Richardson’s syndrome

    • Marina Picillo
    • Maria Francesca Tepedino
    • Paolo Barone

    Original Article Open access 01 February 2022 Pages: 3677 - 3682

    

25. Genetic screening in patients of Meige syndrome and blepharospasm

    • Xinqi Teng
    • Qiang Qu
    • Jian Qu

    Original Article 19 January 2022 Pages: 3683 - 3694

    

26. Negative symptoms in Huntington’s disease

    • Paola Soliveri
    • Dominga Paridi
    • Floriano Girotti

    Original Article 24 January 2022 Pages: 3695 - 3701

    

27. The cognitive phenotypes of Creutzfeldt-Jakob disease: comparison with secondary metabolic encephalopathy

    • Anna Rita Giovagnoli
    • Giuseppe Di Fede
    • Orso Bugiani

    Original Article 28 January 2022 Pages: 3703 - 3716

    

28. The European Portuguese version of the Oxford Cognitive Screening (OCS-Pt): a screening test for acute stroke patients

    • Daniela Valério
    • Jorge Almeida
    • Isabel Santana

    Original Article 13 January 2022 Pages: 3717 - 3728

    

29. Stroke survivors with the same levels of exercise as healthy individuals have lower levels of physical activity

    • Ananda Jacqueline Ferreira
    • Larissa Tavares Aguiar
    • Christina Danielli Coelho de Morais Faria

    Original Article 10 January 2022 Pages: 3729 - 3735

    

30. Effects of stroke etiology on angiographic success in patients undergoing mechanical thrombectomy

    • Cigdem Deniz
    • Aslı Yaman Kula
    • Talip Asil

    Original Article 17 January 2022 Pages: 3737 - 3745

    

31. FLAIR vascular hyperintensity predicts early neurological deterioration in patients with acute ischemic stroke receiving endovascular thrombectomy

    • Ni-Hong Chen
    • Yi-Ming Zhang
    • Ying-Dong Zhang

    Original Article 22 January 2022 Pages: 3747 - 3757

    

32. Brain imaging determinants of functional prognosis after severe endocarditis: a multicenter observational study

    • Yves-Olivier Guettard
    • Alexandre Gros
    • on behalf of the ICE-COCA investigators

    Original Article 29 January 2022 Pages: 3759 - 3768

    

33. Neurotrauma in the Syrian War: analysis of 41,143 cases from July 2013–July 2015

    • Nida Fatima
    • Hani Mowafi
    • Maher Saqqur

    Original Article 12 January 2022 Pages: 3769 - 3774

34. Determinants of hyponatremia following a traumatic brain injury

    • Etienne Léveillé
    • Meshal Aljassar
    • Judith Marcoux

    Original Article 17 January 2022 Pages: 3775 - 3782

    

35. Does erythropoietin affect the outcome and complication rates of patient with traumatic brain injury? A pooled-analysis

    • Yuping Li
    • Jun Zhang
    • Guangyu Lu

    Original Article 19 January 2022 Pages: 3783 - 3793

    

36. Telemedicine application to headache: a critical review

    • Emanuele Spina
    • Gioacchino Tedeschi
    • on behalf of Digital Technologies, Web and Social Media Study Group of the Italian Society of Neurology (SIN)

    Original Article Open access 24 January 2022 Pages: 3795 - 3801

37. Task-switching abilities in episodic and chronic migraine

    • Simone Migliore
    • Giulia D’Aurizio
    • Fabrizio Vernieri

    Original Article 22 January 2022 Pages: 3803 - 3810

    

38. Questionnaire-based survey on the prevalence of medication-overuse headache in Japanese one city—Itoigawa study

    • Masahito Katsuki
    • Chinami Yamagishi
    • Fuminori Yamagishi

    Original Article 19 January 2022 Pages: 3811 - 3822

    

39. Chronic migraine evolution after 3 months from erenumab suspension: real-world-evidence-life data

    • Simona Guerzoni
    • Carlo Baraldi
    • Luca Pani

    Original Article 11 January 2022 Pages: 3823 - 3830

    

40. An invisible cause of disability: stigma in migraine and epilepsy

    • Fulya Basoglu Koseahmet
    • Burcu Polat
    • Musa Ozturk

    Original Article 15 January 2022 Pages: 3831 - 3838

41. Risk factors for posterior reversible encephalopathy syndrome in hypertensive pregnant women presenting with seizures

    • Anish Keepanasseril
    • Deepthi Nayak
    • Baskaran Thilaganathan

    Original Article 29 January 2022 Pages: 3839 - 3846

    

42. The second family affected with a PRDM8-related disease

    • Atefeh Davarzani
    • Amin Shahrokhi
    • Afagh Alavi

    Original Article 16 January 2022 Pages: 3847 - 3855

    

43. Electroclinical spectrum of generalized paroxysmal fast activity in adults without epileptic encephalopathy

    • Leyla Das Pektezel
    • F. Irsel Tezer
    • Serap Saygi

    Original Article 16 January 2022 Pages: 3857 - 3866

    

44. Single nucleotide variants around the connective tissue growth factor (CTGF/CCN2) gene and their association with multiple sclerosis risk, disability scores, and rate of disease progression

    • Birsen Can Demirdöğen
    • Osman Oğuzhan Kılıç
    • Semra Mungan

    Original Article 29 January 2022 Pages: 3867 - 3877

    

45. The prevalence of osteoporosis/osteopenia in patients with multiple sclerosis (MS): a systematic review and meta-analysis

    • Mohaddeseh Azadvari
    • Omid Mirmosayyeb
    • Seyede Zahra Emami Razavi

    Original Article 17 January 2022 Pages: 3879 - 3892

    

46. Serum NfL associated with anti-NMDA receptor encephalitis

    • Xiaoyu Ma
    • Yaxin Lu
    • Yaqing Shu

    Original Article 18 January 2022 Pages: 3893 - 3899

    

47. The detection of up-regulated anti-thyroid antibodies and autoimmune thyroid diseases in patients with autoimmune encephalitis: a retrospective study of 221 patients

    • Jing-Fang Lin
    • Jie-Rui Wang
    • Jin-Mei Li

    Original Article 08 February 2022 Pages: 3901 - 3910

    

48. Efficacy and safety of intravenous high-dose immunoglobulin in treatment of the severe form of Japanese encephalitis

    • Dan Chen
    • Xiaoling Peng
    • Yue Hu

    Original Article 19 January 2022 Pages: 3911 - 3918

    

49. Susac Syndrome: an uncommon cause of impaired vision

    • Paolo Barbero
    • Domizia Vecchio
    • Roberto Cantello

    Original Article Open access 10 January 2022 Pages: 3919 - 3922

    

50. Very low peroneal nerve compound muscle action potential amplitude predicts poor outcome in patients with Guillain-Barré syndrome: a prospective cohort

    • Juan Carlos López-Hernández
    • Javier Andrés Galnares-Olalde
    • Edwin Steven Vargas-Cañas

    Original Article 24 January 2022 Pages: 3923 - 3928